These studies verify the active involvement of E3 ligases in cancer‐promoting inflammatory signalling presenting them as excellent targets for inducing tumour regression via inhibition of NF‐κB tumour‐promotion inflammation. The gene discussed is NFKB1; the disease is neoplasm.